These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16505405)

  • 1. Gadolinium-based contrast media for multi-detector row spiral CT pulmonary angiography in patients with renal insufficiency.
    Morcos SK; Remy-Jardin M
    Radiology; 2006 Mar; 238(3):1077; author reply 1077-8. PubMed ID: 16505405
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-detector row CT angiography of pulmonary circulation with gadolinium-based contrast agents: prospective evaluation in 60 patients.
    Remy-Jardin M; Bahepar J; Lafitte JJ; Dequiedt P; Ertzbischoff O; Bruzzi J; Delannoy-Deken V; Duhamel A; Remy J
    Radiology; 2006 Mar; 238(3):1022-35. PubMed ID: 16505397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of gadolinium-enhanced multi-detector row spiral CT angiography of the chest: preliminary results in 37 patients with contraindications to iodinated contrast agents.
    Remy-Jardin M; Dequiedt P; Ertzbischoff O; Tillie-Leblond I; Bruzzi J; Duhamel A; Remy J
    Radiology; 2005 Jun; 235(3):819-26. PubMed ID: 15845797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal safety of gadolinium-based contrast agent for ionizing radiation imaging.
    Becker J; Thompson H
    Radiology; 2006 Jul; 240(1):301-2; author reply 302. PubMed ID: 16793989
    [No Abstract]   [Full Text] [Related]  

  • 5. A word of caution on the use of high-dose MR contrast media in patients with renal failure.
    Geckeis K; Eggebrecht H; Quick HH; Barkhausen J; Kribben A; Erbel R
    J Endovasc Ther; 2005 Apr; 12(2):262. PubMed ID: 15823076
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)].
    Heuck A; Reiser M
    Internist (Berl); 1997 Dec; 38(12):1234-5. PubMed ID: 9465330
    [No Abstract]   [Full Text] [Related]  

  • 7. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
    Wiginton CD; Kelly B; Oto A; Jesse M; Aristimuno P; Ernst R; Chaljub G
    AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Using low osmolar gadolinium for angiographic imaging and in interventional radiologic procedures in patients with renal failure].
    Strunk H
    Rofo; 2003 Apr; 175(4):571; author reply 571-2. PubMed ID: 12741405
    [No Abstract]   [Full Text] [Related]  

  • 9. Validity of the animal models for nephrogenic systemic fibrosis.
    Morcos SK
    Invest Radiol; 2008 May; 43(5):338; author reply 338. PubMed ID: 18424956
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor.
    Moreno-Romero JA; Segura S; Mascaró JM; Cowper SE; Julià M; Poch E; Botey A; Herrero C
    Br J Dermatol; 2007 Oct; 157(4):783-7. PubMed ID: 17627792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What are the remaining indications for gadolinium contrast in CT].
    Clément O
    J Radiol; 2009 Mar; 90(3 Pt 1):261. PubMed ID: 19421108
    [No Abstract]   [Full Text] [Related]  

  • 12. Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle?
    Bennett LK; Garrett AL
    Cutis; 2008 May; 81(5):421-6. PubMed ID: 18543594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
    Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
    Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSF vs. CIN: Aggregated Screening, Safety, and Protocol Tools for Contrast Imaging in the Setting of Renal Insufficiency.
    Shin J
    J Digit Imaging; 2017 Apr; 30(2):141-143. PubMed ID: 27783172
    [No Abstract]   [Full Text] [Related]  

  • 15. Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography.
    Spinosa DJ; Kaufmann JA; Hartwell GD
    Radiology; 2002 May; 223(2):319-25; discussion 326-7. PubMed ID: 11997531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update.
    Kanal E; Broome DR; Martin DR; Thomsen HS
    Radiology; 2008 Jan; 246(1):11-4. PubMed ID: 17855656
    [No Abstract]   [Full Text] [Related]  

  • 17. Are patients with moderate renal failure at risk for developing nephrogenic systemic fibrosis?
    Saab G; Abu-Alfa A
    Radiology; 2007 Sep; 244(3):930-1; author reply 931-2. PubMed ID: 17709844
    [No Abstract]   [Full Text] [Related]  

  • 18. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?
    Nyman U; Elmståhl B; Leander P; Nilsson M; Golman K; Almén T
    Radiology; 2002 May; 223(2):311-8; discussion 328-9. PubMed ID: 11997530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrogenic systemic fibrosis: possible association with a predisposing infection.
    Golding LP; Provenzale JM
    AJR Am J Roentgenol; 2008 Apr; 190(4):1069-75. PubMed ID: 18356457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium-enhanced computed tomographic angiography: current status.
    Rosioreanu A; Alberico RA; Litwin A; Hon M; Grossman ZD; Katz DS
    Curr Probl Diagn Radiol; 2005; 34(6):207-19. PubMed ID: 16269368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.